Skip to content
Tuesday, November 17, 2026
Major Career Community

Zimbabwe Declines ‘Lopsided’ US Healthcare Assistance Deal Because of Information Apprehensions

Health funding illustration
The offered US funding was intended for programmes for HIV/Aids treatment and prevention, tuberculosis, and malarial diseases.

Zimbabwe has declined a significant US health deal valued at $367m (£272m) spanning five years over Washington's insistence on confidential data.

This rejection was revealed following a government memo from December was disclosed, indicating that President Emmerson Mnangagwa deemed the deal was "lopsided".

An official spokesman later explained that the US was seeking genetic material for research and commercial gain but was unwilling to share the resulting advantages from any future vaccines.

"We must now begin the challenging and unfortunate task of ending our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.

The US Embassy indicated the US had donated more than $1.9bn as health assistance to Zimbabwe during the past two decades.

A medical body in Zimbabwe has urged more dialogue to secure a agreement acceptable to all parties so the nation's critical HIV programme can continue.

Wider Context

Zimbabwe's decision comes after a comparable situation in neighbouring Kenya, where a high court halted a similar health funding agreement after concerns were raised about the security of Kenyans' health data.

Since resuming office last year, US President Donald Trump has reduced overseas assistance and closed the key foreign aid agency.

USAID had managed aid for the US government, but Trump stated its spending was "wasteful" and his administration was pursuing direct bilateral deals to boost openness and accountability.

Based on statements, 16 nations in Africa have so far signed similar health pacts, representing over $18.3bn in new funding.

Specifics of the Declined Deal

The money for Zimbabwe would have gone towards "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".

"We are confident this collaboration would have delivered immense benefits for Zimbabwean communities, particularly the 1.2 million men, women and children currently receiving antiretroviral therapy via American-funded initiatives," Tremont said.

However, official spokesman Nick Mangwana maintained the arrangement was "asymmetrical".

"Our nation was requested to provide its biological resources and data indefinitely, without any corresponding assurance of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that might be developed from that provided information," he stated.

"Put simply, our nation would supply the basic resources for scientific discovery without any certainty that the resulting innovations would be accessible to our people should a future pandemic arise."

Sovereignty and International Frameworks

He also said that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one deals were undermining systems previously established via the international health agency.

The spokesperson cited its Pandemic Benefit-Sharing scheme designed to deal with potential global health emergencies.

"This mechanism is intended to guarantee that when a nation contributes its information, the resulting advantages – including vaccines and treatments – are shared equitably, not commercialised solely by those with the capability to develop them."

These objections regarding the US deal "must not be interpreted as anti-American sentiment," he added.

"We welcome continued discussions with our American counterparts on how subsequent collaboration could be arranged in a way that respects the independence and interests of each country."

Health Experts Response

A leading public health body said it acknowledged the government's concerns, but urged that negotiations must proceed given that much of the nation's Aids initiatives relied on external financing.

"If technical issues arise, including those involving data governance or implementation frameworks, these can often be addressed via detailed discussion and negotiated safeguards," it added.

The situation underscores the complex challenges between accepting vital international aid and protecting a country's data in an increasingly interconnected world.

About the author

Christopher Edwards

Career strategist and former HR director with 15 years of experience in talent development.

Major Career Community

Type to search articles.